Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related THOR
Thoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec
Thoratec Announces HeartMate 3 CE Mark Trial Met Primary Endpoint
Related AMD
PacCrest Analysts Lower PC OEM Estimates En Masse
Mid-Afternoon Market Update: Dow Falls Over 400 Points; Advanced Micro Devices Shares Drop After Disappointing Guidance
Apple Supplier ARM Topples On Mobile Decline; Eyes IoT, Cloud (Investor's Business Daily)

Analysts at Goldman Sachs upgraded Thoratec (NASDAQ: THOR) from “neutral” to “buy.” The target price for Thoratec is set to $46. Thoratec's shares closed at $38.31 on Friday.

Wedbush upgraded Advanced Micro Devices (NYSE: AMD) from “neutral” to “outperform.” The target price for Advanced Micro Devices has been raised from $4.50 to $5. AMD's shares closed at $3.83 on Friday.

Analysts at Cowen & Company upgraded St. Jude Medical (NYSE: STJ) from “underperform” to “market perform.” The target price for St. Jude Medical has been raised from $38 to $53. St. Jude Medical's shares closed at $55.16 on Friday.

Analysts at Miller Tabak upgraded Dunkin' Brands Group (NASDAQ: DNKN) from “hold” to “buy.” The target price for Dunkin' Brands Group has been raised from $46 to $53. Dunkin' Brands Group's shares closed at $45.68 on Friday.

Latest Ratings for THOR

DateFirmActionFromTo
Sep 2015BMO CapitalUpgradesMarket PerformOutperform
Aug 2015Leerink SwannDowngradesOutperformMarket Perform
Aug 2015Raymond JamesDowngradesOutperformMarket Perform

View More Analyst Ratings for THOR
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (AMD + DNKN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters